000 01406 a2200421 4500
005 20250513124606.0
264 0 _c19971014
008 199710s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/hum.1997.8.12-1459
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavis, J L
245 0 0 _aRetroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies.
_h[electronic resource]
260 _bHuman gene therapy
_cAug 1997
300 _a1459-67 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _a3T3 Cells
_xvirology
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xgenetics
650 0 4 _aHumans
650 0 4 _aKidney
_xcytology
650 0 4 _aMelanoma
_xgenetics
650 0 4 _aMice
650 0 4 _aRecombinant Proteins
_xgenetics
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aTransduction, Genetic
650 0 4 _abeta-Galactosidase
_xgenetics
700 1 _aWitt, R M
700 1 _aGross, P R
700 1 _aHokanson, C A
700 1 _aJungles, S
700 1 _aCohen, L K
700 1 _aDanos, O
700 1 _aSpratt, S K
773 0 _tHuman gene therapy
_gvol. 8
_gno. 12
_gp. 1459-67
856 4 0 _uhttps://doi.org/10.1089/hum.1997.8.12-1459
_zAvailable from publisher's website
999 _c9266013
_d9266013